Shapeways Appoints Leslie C. G. Campbell to Board of Directors

$COUP
$LVOX
$PETS
$SHPW
Computer Software: Prepackaged Software
Technology
EDP Services
Technology
Get the next $COUP alert in real time by email

Shapeways, Inc. (NYSE:SHPW) ("the Company"), a leader in the large and fast-growing digital manufacturing industry, announced today the appointment of Leslie C. G. Campbell to the Company's Board of Directors. Ms. Campbell will serve as an independent member of the Board, and as chair of the Compensation committee as well as a member of the Nominating and Corporate Governance committee.

"Following Shapeways' recent listing on the NYSE, we are pleased to welcome Leslie to our board of directors as we continue to build a best in class company with strong governance," said Greg Kress, the Company's Chief Executive Officer. "Leslie is an accomplished business leader with more than 30 years of multi-disciplinary experience in the technology, finance, software and information services industries, which will be invaluable to us as we execute on our strategy and grow our digital manufacturing platform."

Josh Wolfe, Chairman of the Board, added, "We are excited to welcome Leslie to the Shapeways board. She brings extensive public board expertise, relevant tech experience, and we look forward to her insights and contributions as the entire Shapeways team continues to focus on growth and creating shareholder value."

Ms. Campbell added, "I am excited to join Shapeways, leverage my background and experiences, and help management execute on their vision to digitize manufacturing. Shapeways has the ability to leverage their software to enable broad market adoption of additive manufacturing and support other manufacturers in their digital transformation."

Ms. Campbell previously served as Chief Procurement Officer for Reed Elsevier, a world leading provider of professional information solutions, where she transformed the global procurement and related operating functions, was named by Supply Chain Digital as one of the top CPOs in the world, and was recognized by (SAP) Ariba with their lifetime achievement award. Prior to Reed Elsevier, she held various senior executive roles at Oracle Corporation and at Dell, Inc., and spent a number of years based in Europe as Dell's Vice President and General Manager of the EMEA Global Segment where she led the business unit comprising Dell's largest global customers. She began her career at KPMG, serving first in audit and later in the international high technology tax practice and is recognized as an SEC audit committee financial expert. Ms. Campbell earned a B.A. degree in Business Administration from the University of Washington.

In addition to her operating experience, Ms. Campbell currently serves on the boards of Coupa Software (NASDAQ:COUP) where she chairs the Nominating and Corporate Governance committee and serves on the Audit committee, PetMed Express (NASDAQ:PETS) where she chairs the Nominating and Governance committee and serves on the Audit and Compensation committees, and LiveVox Holdings (NASDAQ:LVOX) where she chairs the Audit committee. She was recently awarded NACD Directorship Certification™ and was named to WomenInc. magazine's list of Most Influential Corporate Board Directors.

About Shapeways

Shapeways is a leader in the large and fast-growing digital manufacturing industry combining high quality, flexible on-demand manufacturing powered by purpose-built proprietary software which enables customers to rapidly transform digital designs into physical products, globally. Shapeways makes industrial-grade additive manufacturing accessible by fully digitizing the end-to-end manufacturing process, and by providing a broad range of solutions utilizing 11 additive manufacturing technologies and more than 90 materials and finishes, with the ability to easily scale new innovation. To date, Shapeways has delivered over 21 million parts to 1 million customers in over 160 countries.

Get the next $COUP alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$COUP
$LVOX
$PETS
$SHPW

CompanyDatePrice TargetRatingAnalyst
8/1/2023$3.50Buy
The Benchmark Company
5/25/2023$20.00Buy
Lake Street
12/12/2022Neutral → Outperform
SMBC Nikko
10/20/2022$67.00 → $55.00Neutral → Underweight
Piper Sandler
9/23/2022$2.50Neutral
Credit Suisse
9/23/2022$60.00Underperform
Credit Suisse
9/1/2022$77.00Buy
Citigroup
8/22/2022$65.00 → $55.00Sector Perform → Underperform
RBC Capital Mkts
More analyst ratings

$COUP
$LVOX
$PETS
$SHPW
Press Releases

Fastest customizable press release news feed in the world

See more
  • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

    DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

    DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMed Express, Inc. to Participate in the 27th Annual ICR Conference

    DELRAY BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the 27th Annual ICR Conference, to be held January 13-15, 2025 in Orlando, FL. Sandra Campos, Chief Executive Officer and President, and Robyn D'Elia, Chief Financial Officer, will meet with investors and present at approximately 11:00 a.m. Eastern Time on Monday, January 13, 2025. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet health

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$COUP
$LVOX
$PETS
$SHPW
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$COUP
$LVOX
$PETS
$SHPW
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$COUP
$LVOX
$PETS
$SHPW
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$COUP
$LVOX
$PETS
$SHPW
Leadership Updates

Live Leadership Updates

See more
  • PetMed Express, Inc. Announces Appointment of Robyn D'Elia as Chief Financial Officer

    DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer

    DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team

    Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$COUP
$LVOX
$PETS
$SHPW
Financials

Live finance-specific insights

See more
  • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

    DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

    DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • PetMeds® Adopts Limited Duration Shareholder Rights Plan

    DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$COUP
$LVOX
$PETS
$SHPW
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more